A full exit during a volatile stretch raises a sharper question than timing alone.California-based Foresite Capital Management VI fully exited Edgewise Therapeutics (EWTX 6.57%) in the quarter ended September 30, reducing its position by 585,000 shares worth about $7.67 million.What HappenedAccording to a filing with the U.S. Securities and Exchange Commission dated November 14, Foresite Capital Management VI LLC sold its entire stake in Edgewise Therapeutics (EWTX 6.57%) during the third quarter. The trade ...